Allergan's Botox receives complete response letter for upper limb spasticity
28 May 2009
Katie McQue
Please Login to read the full article.
28 May 2009
Katie McQue
katie.mcque@informa.com
The US FDA has issued a complete response letter to Allergan for its supplemental BLA on its botulinum Type A product, Botox, for the treatment of upper limb spasticity in stroke patients.
"A significant unmet medical need for those suffering from upper limb spasticity exists in the US....
Please Login to read the full article.
RELATED CONTENT
NEWS
- Once, twice, three times approval for Botox but SMC frowns on Merz' cover
- Revance raises $45M for a needle-free wrinkle on botox market expansion
- European positive opinion for Allergan's Botox for neurogenic bladder incontinence
- US FDA panel to weigh anaesthesia use in children
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
